{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Moxifloxacin+400-mg&page=4", "query": { "intervention": "Moxifloxacin 400-mg", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 134, "total_pages": 14, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Moxifloxacin+400-mg&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Moxifloxacin+400-mg&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T15:24:06.986Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02243241", "title": "The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "HYD", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo for HYD", "type": "DRUG" }, { "name": "Placebo for moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Purdue Pharma LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 208, "start_date": "2012-11", "completion_date": "2013-05", "has_results": false, "last_update_posted_date": "2014-09-17", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02243241" }, { "nct_id": "NCT02136888", "title": "Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Ponesimod Placebo", "type": "DRUG" }, { "name": "Moxifloxacin Placebo", "type": "DRUG" }, { "name": "Ponesimod 10 mg", "type": "DRUG" }, { "name": "Ponesimod 20 mg", "type": "DRUG" }, { "name": "Ponesimod 40 mg", "type": "DRUG" }, { "name": "Ponesimod 60 mg", "type": "DRUG" }, { "name": "Ponesimod 80 mg", "type": "DRUG" }, { "name": "Ponesimod 100 mg", "type": "DRUG" }, { "name": "Moxifloxacin 400 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actelion", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 116, "start_date": "2011-08", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2014-05-13", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02136888" }, { "nct_id": "NCT05933447", "title": "Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Rodatristat Ethyl", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo for Rodatristat", "type": "DRUG" }, { "name": "Placebo for Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Altavant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 27, "start_date": "2023-05-12", "completion_date": "2023-07-28", "has_results": false, "last_update_posted_date": "2023-10-03", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05933447" }, { "nct_id": "NCT01297062", "title": "A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "Exenatide", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 94, "start_date": "2011-02", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2015-04-14", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Evansville, Indiana", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01297062" }, { "nct_id": "NCT01860703", "title": "Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Prolonged QTc Interval" ], "interventions": [ { "name": "Deferiprone", "type": "DRUG" }, { "name": "deferiprone matching placebo tablets", "type": "DRUG" }, { "name": "moxifloxacin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ApoPharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 50, "start_date": "2012-11", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2014-11-12", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01860703" }, { "nct_id": "NCT01537887", "title": "A Study of LY2484595 on the Electrical Activity of the Heart", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "LY2484595", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 72, "start_date": "2012-02", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2019-03-07", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Evansville, Indiana", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01537887" }, { "nct_id": "NCT01516255", "title": "Effect of Liraglutide on Heart Frequency in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "liraglutide", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "moxifloxacin", "type": "DRUG" }, { "name": "electrocardiogram (ECG)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 64, "start_date": "2006-07", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2017-01-25", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01516255" }, { "nct_id": "NCT01287793", "title": "Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "tigecycline", "type": "DRUG" }, { "name": "moxifloxacin", "type": "DRUG" }, { "name": "100 mL 0.9% Sodium Chloride intravenous", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 48, "start_date": "2011-01", "completion_date": "2011-05", "has_results": false, "last_update_posted_date": "2011-05-24", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287793" }, { "nct_id": "NCT03554304", "title": "Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "QT/QTc Interval in Healthy Volunteers" ], "interventions": [ { "name": "WCK 5222", "type": "DRUG" }, { "name": "IV placebo matched to WCK 5222 / Moxifloxacin IV solution", "type": "DRUG" }, { "name": "Moxifloxacin 400-mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wockhardt", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 60, "start_date": "2017-02-09", "completion_date": "2017-10-06", "has_results": false, "last_update_posted_date": "2018-06-13", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03554304" }, { "nct_id": "NCT06161220", "title": "A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiac Repolarization in Healthy Subjects" ], "interventions": [ { "name": "Carbidopa capsule", "type": "DRUG" }, { "name": "Moxifloxacin Tablets, USP", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Impax Laboratories, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 35, "start_date": "2023-10-30", "completion_date": "2023-12-05", "has_results": false, "last_update_posted_date": "2024-03-05", "last_synced_at": "2026-10-10T15:24:06.986Z", "location_count": 1, "location_summary": "Dilworth, Minnesota", "locations": [ { "city": "Dilworth", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06161220" } ] }